Chronic Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-11-26Clinical Trial Update: IIT PH1 KDS-1001 in Patients With CML [Phase 1]
The IIT Phase 1 trial of KDS-1001 in chronic myeloid leukemia has been withdrawn.
-
EMA withdrawal · 2022-07-05EMA Withdrawn: Imatinib Actavis (imatinib) — Actavis Group PTC ehf
EMA withdrawn Imatinib Actavis (imatinib) from the market, with indications including chronic myeloid leukemia, precursor B-ALL/lymphoma, my…
-
CLINICAL_TRIALS withdrawal · 2017-12-05Clinical Trial Update: StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies [Phase 2]
Phase 2 trial evaluating StemRegenin-1-expanded versus unexpanded umbilical cord blood for high-risk hematologic malignancies has been withd…
-
CLINICAL_TRIALS withdrawal · 2017-04-20Clinical Trial Update: Trial Evaluating Nilotinib as Treatment for Newly Diagnosed CML Patients in Accelerated Phase. [Phase 4]
Phase 4 trial evaluating nilotinib for newly diagnosed chronic myeloid leukemia in the accelerated phase has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-02-01Clinical Trial Update: Imatinib Response in Patients With Chronic Myeloid Leukemia (CML) in Function of Abl Polymorphisms
A clinical trial evaluating imatinib response in chronic-phase chronic myeloid leukemia as a function of Abl polymorphisms has been withdraw…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-08-15Clinical Trial Update: Imatinib and BL-8040 (Novel Anti CXCR4 Antagonist) for Improving Molecular Response in Chronic Myelogenous Leukemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating imatinib in combination with the CXCR4 antagonist BL-8040 for improving molecular response in chronic …
-
CLINICAL_TRIALS withdrawal · 2016-07-14Clinical Trial Update: Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies [Phase 2]
A Phase 2 clinical trial evaluating single or double donor umbilical cord blood transplant for high-risk hematologic malignancies has been w…
-
CLINICAL_TRIALS withdrawal · 2016-04-20Clinical Trial Update: Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders
A clinical trial (NCT02663648) evaluating a cell cycle regulatory gene study in myeloproliferative neoplasms has been withdrawn by the spons…
-
CLINICAL_TRIALS withdrawal · 2016-02-17Clinical Trial Update: Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL [Phase 2, Phase 3]
The trial studying dasatinib in imatinib-resistant or intolerant chronic myeloid leukemia or Philadelphia chromosome‑positive acute lymphobl…
-
CLINICAL_TRIALS withdrawal · 2016-02-17Clinical Trial Update: Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia [Phase 1]
A Phase 1 trial evaluating the combination of ipilimumab and dasatinib in patients with chronic or accelerated chronic myeloid leukemia has …
-
CLINICAL_TRIALS withdrawal · 2016-02-17Clinical Trial Update: Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase [Phase 1]
A Phase I trial evaluating dasatinib in combination with imatinib for chronic myeloid leukemia in chronic phase has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-31Clinical Trial Update: A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid Malignancies [Phase 1]
A Phase I study of an alloreactive cell infusion following transplantation of haplotype cells in patients with myeloid malignancies has been…
-
CLINICAL_TRIALS withdrawal · 2015-08-25Clinical Trial Update: Autologous Stem Cell Transplants for Chronic Myelogenous Leukemia [Phase 2]
Phase 2 trial evaluating autologous stem cell transplantation for chronic myeloid leukemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-05-15Clinical Trial Update: RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease. [Phase 1, Phase 2]
A Phase 1/2 study of everolimus (RAD001) in patients with chronic phase chronic myeloid leukemia with molecular disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-03-15Clinical Trial Update: Compassionate Use Ponatinib
This clinical trial update indicates that the compassionate-use program for ponatinib is no longer available.
-
CLINICAL_TRIALS withdrawal · 2012-11-19Clinical Trial Update: Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating combination chemotherapy followed by peripheral stem cell transplantation for chronic myeloid leukemia…
-
CLINICAL_TRIALS withdrawal · 2012-05-10Clinical Trial Update: Palifermin After Haploidentical PBSCT [Phase 2]
A Phase 2 trial evaluating palifermin after haploidentical peripheral blood stem cell transplantation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-08-26Clinical Trial Update: Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia
Expanded access program for nilotinib (AMN107) in adults with imatinib-resistant or intolerant chronic myeloid leukemia has ended; the progr…
-
CLINICAL_TRIALS withdrawal · 2011-04-28Clinical Trial Update: Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia [Phase 1, Phase 2]
A Phase 1/2 trial evaluating an allogeneic tumor cell vaccine for chronic myeloid leukemia was withdrawn.
-
EMA withdrawal · 2011-01-31EMA Application withdrawn: Tekinex (omacetaxine mepesuccinate) — ChemGenex Europe SAS
EMA withdrew the Tekinex application for omacetaxine mepesuccinate (ChemGenex Europe SAS) for chronic myeloid leukemia with BCR-ABL positive…
-
CLINICAL_TRIALS withdrawal · 2008-10-31Clinical Trial Update: A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating CLAG with imatinib (Gleevec) for refractory/relapsed chronic myeloid leukemia and acute myeloid leukemia has been w…